MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹10,233 Cr |
| Mar2024 | ₹5.27 Cr |
| Mar2023 | ₹-740 Cr |
| Mar2022 | ₹605 Cr |
| Mar2021 | ₹-7.81 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,233 Cr | 194,066.22 | |
| Mar2024 | ₹5.27 Cr | Positive | |
| Mar2023 | ₹-740 Cr | Negative | |
| Mar2022 | ₹605 Cr | Positive | |
| Mar2021 | ₹-7.81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹94,120.5 Cr | 12.5% | 8.5% | -8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 12.5% |
8.5% |
-8.2% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses